FIXED PHARMACEUTICAL CONDITIONS FOR TREATMENT OF HEMATOPOIETIC CANCERS AND PROLIFERATIVE DISORDERS

• 收藏
• 分享

专利权人:

Celator Pharmaceuticals; Inc.

发明人:

LOUIE, Arthur,SWENSON, Christine,MAYER, Lawrence,JANOFF, Andrew

申请号：

DK08730048

公开号：

DK2120568T3

申请日:

2008.02.15

申请国别(地区):

DK

年份:

2017

代理人:

摘要：

Provided herein is a pharmaceutical composition comprising cytarabine and daunorubicin at a fixed, non-antagonistic molar ratio encapsulated in liposomes for use in the treatment of patients with hematologic disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/